ArticleDiabetes & metabolism journal2023

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404).

Tzu-Yi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.